Cas:6299-67-8 2,3-DIMETHOXYANILINE manufacturer & supplier

Chemical Name:2,3-DIMETHOXYANILINE

CAS.NO:6299-67-8

Synonyms:Benzenamine, 2,3-dimethoxy-;2,3-DIMETHOXYANILINE

Molecular Formula:C₈H₁₁NO₂

Molecular Weight:153.178

HS Code:2922299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:250.1±20.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.540

PSA:44.48000

Exact Mass:153.078979

LogP:0.90

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzenamine, 2,3-dimethoxy- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-DIMETHOXYANILINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenamine, 2,3-dimethoxy- Use and application,Benzenamine, 2,3-dimethoxy- technical grade,usp/ep/jp grade.

Related News: She said she revealed her diagnosis in the interest of transparency but in truth really mostly as a shoutout to early diagnosis,” and wanted to “urge women to educate themselves on this disease; to get all the regular screenings and scans that you can; to always listen to your bodies; and of course to ensure that your legitimate medical concerns are not dismissed or diminished. 2,3-DIMETHOXYANILINE manufacturer Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 2,3-DIMETHOXYANILINE supplier As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made due to the continued drop in demand for travel to China and the US Department of State��s decision to raise its China travel advisory to a Level 4. 2,3-DIMETHOXYANILINE vendor Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress. 2,3-DIMETHOXYANILINE factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).